Skip to content
ppharmaranks
Menu

Best treatments for venous thrombosis

4 products may treat venous thrombosis, spanning FDA drug classes such as direct thrombin inhibitor, factor xa inhibitor. The current highest-rated option is pradaxa. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.

Quick answer: Of the 4 drugs we list for venous thrombosis, 2 are available as lower-cost generics, spanning classes such as direct thrombin inhibitor, factor xa inhibitor. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for venous thrombosis — so confirm the right choice with your prescriber.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Top-rated picks for venous thrombosis: 1. Pradaxa · 2. Xarelto · 3. Eliquis

Top-rated treatments for venous thrombosis, ranked by pharmaranks score
#DrugRatingPharmacy pays
172/100$27View →
270/100$1View →
3Not yet ratedView →
4Not yet ratedView →

Full ranking · 4 treatments

Frequently asked

What treats venous thrombosis?
Our catalog lists 4 products that may treat venous thrombosis, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is pradaxa.
What is the best-rated treatment for venous thrombosis?
By our independent recall-safety rating — not an efficacy measure — pradaxa ranks highest among the products we list for venous thrombosis. Always consult a professional.
How are these treatments ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
What types of drugs treat venous thrombosis?
Treatments for venous thrombosis span FDA drug classes including direct thrombin inhibitor, factor xa inhibitor. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.